4.100PLN-1.91%Mkt Cap: 352.04M PLNP/E: 102.50Last update: 2026-06-01
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap352.04M PLN
Enterprise Value407.79M PLN
Revenue (TTM)282.52M PLN
Gross Profit91.80M PLN
Net Income (TTM)3.39M PLN
Revenue/Share3.290 PLN
Last Price4.100 PLN
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLBIOTN00029
Valuation
P/E (Trailing)102.50
P/E (Forward)—
PEG—
EV/EBITDA7.88
EV/Revenue1.44
P/S1.27
P/B0.60
EPS (TTM)0.04
EPS (Forward)—
52W Range
3.65043% of range4.700
52W High4.700 PLN
52W Low3.650 PLN
Profitability
Gross Margin32.49%
Oper. Margin5.99%
EBITDA Margin18.33%
Profit Margin1.20%
ROE0.57%
ROA0.44%
Growth
Revenue Growth-17.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF22.62M PLN
CapEx (TTM)13.07M PLN
FCF Margin2.54%
FCF Yield2.04%
Net Debt48.88M PLN
Net Debt/EBITDA0.94
Balance Sheet
Debt/Equity0.10
Current Ratio1.41
Quick Ratio0.49
Book Value/Sh6.918 PLN
Cash/Share0.0960 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJan 13, 2014
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.85.86M
Float43.09M
Insiders54.85%
Institutions0.28%
Technical
SMA 504.224 (-2.9%)
SMA 2004.166 (-1.6%)
Beta0.16
S&P 52W Chg27.94%
Avg Vol (30d)53.18K
Avg Vol (10d)66.80K
Technical Indicators
RSI (14)43.3
MACD0.0078
MACD Signal0.0236
MACD Hist.-0.0158
BB Upper4.420 PLN
BB Middle4.253 PLN
BB Lower4.087 PLN
BB Width7.82%
ATR (14)0.1247 PLN
Vol Ratio (20d)1.75x